RESOLUTE ONYX China RCT Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 550 participants.

Also called NCT03466151

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 550 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03466151
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03466151. Randomized; no masking; primary purpose treatment. Start 2018-04-12 (actual); primary completion 2021-02-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RESOLUTE ONYX China RCT Study
Condition
Ischemic Heart Disease
Condition
Stenotic Coronary Lesion
Condition
Cardiovascular Diseases
Condition
Arteriosclerosis
Intervention (Device)
Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
Intervention (Device)
Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct03466151
Content hash
13aa7609b1535dea4b6cb25867e0d35b3e09da0274aa1707b8118ff59621c6f8